EMA: Placebo Trials for Lipid Disorders No Longer Acceptable

Drug Industry Daily
A A
The European Medicines Agency (EMA) says it is no longer acceptable for sponsors to conduct placebo-controlled clinical trials when developing monotherapy drugs for lipid disorders.

To View This Article:

Login

Subscribe To Drug Industry Daily